Search

Your search keyword '"CHEN CHENG, Kuo"' showing total 28 results

Search Constraints

Start Over You searched for: Author "CHEN CHENG, Kuo" Remove constraint Author: "CHEN CHENG, Kuo" Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
28 results on '"CHEN CHENG, Kuo"'

Search Results

1. Miscellaneous Disorder of the Small Intestines

2. Applying Deep Learning Model to Predict Diagnosis Code of Medical Records

4. Applying Deep Learning Model to Predict Diagnosis Code of Medical Records

5. Combined CRAFITY score and α-fetoprotein response predicts treatment outcomes in patients with unresectable hepatocellular carcinoma receiving anti-programmed death-1 blockade-based immunotherapy

8. Deep-ADCA: Development and Validation of Deep Learning Model for Automated Diagnosis Code Assignment Using Clinical Notes in Electronic Medical Records

11. Measurement of hadronic cross-section and preliminary results on the pion form-factor using the radiative return at DAPHNE

12. Study of the decay phi -> pi(+)pi(-)pi(0) with the KLOE detector

13. Measurement of Gamma (phi-> eta-prime gamma) / Gamma (phi -> eta gamma) and the pseudoscalar mixing angle

14. Study of the decay phi ->pi(0)pi(0)gamma with the KLOE detector

15. Measurement of Gamma(KS->pi+pi-gamma)/Gamma(KS->pi0pi0)

16. Detection of phi -> eta' gamma, phi -> eta gamma in pi+ pi- gamma gamma gamma final state with KLOE at DAPHNE

20. Extension of deep-ultraviolet lithography for patterning logic gates using alternating phase shifting masks

21. Data acquisition and monitoring for the KLOE detector

22. The KLOE electromagnetic calorimeter

23. The QCAL tile calorimeter of KLOE

24. Study of the decay phi ->eta pi(0)gamma with the KLOE detector

26. Combined CRAFITY score and α-fetoprotein response predicts treatment outcomes in patients with unresectable hepatocellular carcinoma receiving anti-programmed death-1 blockade-based immunotherapy.

27. Alpha-fetoprotein response predicts treatment outcomes in patients with unresectable hepatocellular carcinoma receiving immune checkpoint inhibitors with or without tyrosine kinase inhibitors or locoregional therapies.

28. Predictors of response and survival in patients with unresectable hepatocellular carcinoma treated with nivolumab: real-world experience.

Catalog

Books, media, physical & digital resources